General Psychiatry
General Psychiatry RSS Feed RSS

How to Diagnose ADHD in Bipolar Disorder

September 28, 2021
Chris Aiken, MD.
Chris Aiken, MD. Editor-in-Chief of TCPR. Practicing psychiatrist, Winston-Salem, NC. Dr. Aiken has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.  
Most patients with bipolar disorder have cognitive complaints, but it’s a mistake to diagnose them all with ADHD, and a mistake to miss the genuine ADHD-bipolar comorbidity as well. Inside, a step-by-step guide to teasing apart the diagnoses.
Read More

Brexpiprazole Ineffective in Mania

September 28, 2021
Richard Moldawsky, MD.
Richard Moldawsky, MD. Dr. Moldawsky has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Choosing an antipsychotic in bipolar disorder just got more complicated. This series of industry-sponsored trials reveals that their anti-manic activity may not be a class effect.
Read More
RESEARCH UPDATE

Omega-3s and Metabolic Risks in Schizophrenia

September 28, 2021
Batya Swift Yasgur, MA, LSW, and Chris Aiken, MD.
Batya Swift Yasgur, MA, LSW, and Chris Aiken, MD. The authors have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Omega-3s are helpful for negative symptoms in schizophrenia, and this study suggests they may have metabolic benefits as well.
Read More

Atomoxetine: Myths and Truths

September 10, 2021
Jason Mallo, DO
Jason Mallo, DO. Attending psychiatrist, Maine Medical Center, Portland, ME. Dr. Mallo has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
From ADHD to off-label uses, we detail how to dose atomoxetine, how pharmacogenomic testing affects it, and how it compares with stimulants and the other antidepressant for ADHD, viloxazine (Qelbree).
Read More

Overdiagnosis in Psychiatry

September 10, 2021
Joel Paris, MD
Joel Paris, MDJoel Paris, MD

Professor emeritus at McGill University, and senior psychiatrist and research associate at Sir Mortimer B. Davis-Jewish General Hospital. Dr. Paris is the former editor of the Canadian Journal of Psychiatry and the author of 25 books including Overdiagnosis in Psychiatry, 2nd ed. (Oxford University Press; 2020). Dr. Paris has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Joel Paris explains why adult ADHD, depression, bipolar II, PTSD, and borderline personality are overdiagnosed in psychiatry at the expense of schizophrenia.
Read More

Psilocybin vs Escitalopram for Depression

September 10, 2021
Michael Posternak, MD.
Michael Posternak, MD. Dr. Posternak has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Psilocybin is inching its way toward FDA approval in depression, but will this trial from the New England Journal of Medicine help it along or set it back?
Read More
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
Featured Video
Featured Podcast
Recommended

About

Shop Online

Newsletters

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.